The Retina Group of Washington | Chevy Chase, MD

Research site
5454 Wisconsin Avenue Suite 650, Chevy Chase, Maryland, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 10
Status: Active
Trial type: Interventional
Funder type: Industry

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration

Patients who completed Study ISEE2008 (GATHER2) and consent to participate will be administered monthly avacincaptad pegol 2 mg.

Active, not recruiting
Macular Degeneration
Geographic Atrophy
Drug: Avacincaptad pegol 2 mg intravitreal injection

Trial conditions

Macular Degeneration (8 trials)
Atrophy (5 trials)
Geographic Atrophy (5 trials)
Anterior Uveitis (1 trial)
Cataract (1 trial)
Eye Diseases (1 trial)
Intermediate Uveitis (1 trial)
Macular Edema (1 trial)
Neoplasm Metastasis (1 trial)
Panuveitis (1 trial)

And 4 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems